Effects of ruxolitinib cream in patients with atopic dermatitis with baseline body surface area ≥10% and Eczema Area and Severity Index score ≥16: Pooled results from two phase 3 studies

被引：0
|
作者：
Simpson, Eric L. [1 ]
Kircik, Leon [2 ]
Blauvelt, Andrew [3 ]
Kuligowski, Michael E. [4 ]
Venturanza, May E. [4 ]
Sun, Kang [4 ]
Eichenfield, Lawrence F. [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Oregon Med Res Ctr, Tigard, OR USA
[4] Incyte Corp, Wilmington, DE USA
[5] Univ Calif San Diego, San Diego, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27620
引用
收藏
页码：AB157 / AB157
页数：1
相关论文
共 50 条
  • [31] Long-term safety and disease control with ruxolitinib cream in patients with atopic dermatitis based on previous medication history: pooled results from two phase III studies
    Blauvelt, A.
    Eichenfield, L. F.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E136 - E137
  • [32] Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Ren, Haobo
    Brar, Kanwaljit K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB180 - AB180
  • [33] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E134 - E135
  • [34] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from two phase III randomized double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E116 - E117
  • [35] Crisaborole ointment improves global atopic dermatitis severity across patients with varying baseline characteristics: pooled results from two phase III trials
    Paller, A. S.
    Luger, T. A.
    Hebert, A. A.
    Zaenglein, A. L.
    Silverberg, J. I.
    Tallman, A. M.
    Tan, H.
    Ports, W. C.
    Zielinski, M. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E39 - E40
  • [36] Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trials
    Jacobson, M. E.
    Seshadri, R. S.
    Bissonnette, R.
    Paller, A. S.
    Weidinger, S.
    Thyssen, J. P.
    Hester, B.
    Simpson, E. L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (10) : e830 - e832
  • [37] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Leung, Donald Y. M.
    Forman, Seth B.
    Venturanza, May E.
    Sun, Kang
    Kuligowski, Michael E.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 863 - 872
  • [38] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, J. F.
    Sidbury, B.
    Zaenglein, A. L.
    Pariser, D. M.
    Cook-Bolden, F. E.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 66 - 66
  • [39] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, J.
    Sidbury, R.
    Zaenglein, A. L.
    Pariser, D. M.
    Cook-Bolden, F. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S193 - S193
  • [40] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, Joseph
    Sidbury, Robert
    Zaenglein, Andrea
    Pariser, David
    Cook-Bolden, Fran
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB86 - AB86
12345